Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Asset Utilization Ratio for 13 consecutive years, with 0.66 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 13.32% year-over-year to 0.66, compared with a TTM value of 0.66 through Oct 2025, up 13.32%, and an annual FY2025 reading of 0.6, up 14.41% over the prior year.
  • Asset Utilization Ratio was 0.66 for Q4 2025 at Pharma-Bio Serv, down from 0.67 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.01 in Q3 2022 and bottomed at 0.58 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 0.77, with a median of 0.74 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 45.34% in 2022, then tumbled 30.95% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.77 in 2021, then increased by 23.59% to 0.95 in 2022, then decreased by 10.78% to 0.84 in 2023, then crashed by 30.95% to 0.58 in 2024, then rose by 13.32% to 0.66 in 2025.
  • Business Quant data shows Asset Utilization Ratio for PBSV at 0.66 in Q4 2025, 0.67 in Q3 2025, and 0.64 in Q2 2025.